Pharmaceutical News and Articles

Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine

The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately diagnoses Meni

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma

The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with relapsed or refractory follicular lymphom

Lilly's Oral GLP-1, Orforglipron, Showed Compelling Efficacy and a Safety Profile Consistent with Injectable GLP-1 Medicines, in Complete Phase 3 Results

Eli Lilly and Company (NYSE LLY) today announced detailed results from ACHIEVE-1, a Phase 3 trial evaluating the safety and efficacy of orforglipron compared to

Lilly's Once-Weekly Insulin Efsitora Alfa Demonstrated A1C Reduction and a Safety Profile Consistent with Daily Insulin in Multiple Phase 3 Trials

Eli Lilly and Company (NYSE LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials evaluating the safety and efficacy

Novo Nordisk's Mim8 Prophylaxis Treatment Shown to be Well-Tolerated When Switching from Emicizumab in People with Hemophilia A in New Phase 3 Data

Bagsv rd, Denmark, 22 June 2025 Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (den

Incyte Announces FDA Approval of Monjuvi (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Dupixent (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Nightmares Might Be Slowly Scaring Some To Death

MONDAY, June 23, 2025 Scared to death might not be just a saying, as far as nightmares are concerned. People who have frequent nightmares appear to have a tripl

Blood Test Might Predict Rapid Decline in Alzheimer's Patients

MONDAY, June 23, 2025 A common blood test can flag early Alzheimer s disease patients who are four times more likely to experience rapid brain decline, a new st

Weed Use Linked To Heart-Related Deaths

MONDAY, June 23, 2025 Weed is associated with a doubled risk of death from heart disease, a new evidence review shows. The study also found that marijuana use i